Medtronic, Inc. (MDT) PT Lowered to $85 at Leerink Partners; Hurricane Maria a Significant Headwind
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil settles higher as weak U.S. economic growth offset by supply concerns
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
Medtronic, Inc. (MDT) PT Lowered to $89 at BMO Capital; 'Updating Model for Hurricane Maria... $250M Impact to Manufacturing in PR'
October 10, 2017 10:07 AM EDTBMO Capital lowered its price target on Medtronic, Inc. (NYSE: MDT) to $89.00 (from $92.00) while maintaining a Outperform rating, following a model update due to impact of Hurricane Maria.
Analyst Joanne Wuensch notes a cautious outlook following a model update with management citing a $250... More
Medtronic, Inc. (MDT) PT Lowered to $94 at Needham & Company; 'Lowering Estimates for Hurricane Maria Manufacturing Impact'
October 10, 2017 7:59 AM EDTNeedham & Company lowered its price target on Medtronic, Inc. (NYSE: MDT) to $94.00 (from $95.00) while maintaining a Buy rating, following an update on the impact of Hurricane Maria.
Analyst Mike Matson notes a cautious outlook, as the company reported damage caused by Hurricane Maria... More
Medtronic (MDT) Granted FDA Approval for Endurant II/IIs Stent Graft System
October 9, 2017 8:07 AM EDTMedtronic plc (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the Endurant(TM) II/IIs stent graft system to treat abdominal aortic aneurysm (AAA) patients with neck lengths down to 4mm and... More
Medtronic, Inc. (MDT) PT Lowered to $83 at Stifel on Hurricane Maria Update; 'Four Major Manufacturing Facilities Sustained Some Damage'
October 9, 2017 7:47 AM EDTStifel lowered its price target on Medtronic, Inc. (NYSE: MDT) to $83.00 (from $91.00) while maintaining a Hold rating, following the company's update on Hurricane Maria in Puerto Rico.
Analyst Rick Wise notes a cautious outlook following the company's update on Hurricane Maria in Puerto... More
Wells Fargo Downgrades Medtronic, Inc. (MDT) to Market Perform, Guidance Looks Aggressive
October 9, 2017 2:48 AM EDTWells Fargo downgraded Medtronic, Inc. (NYSE: MDT) from Outperform to Market Perform with a price target of $83.00 (from $93.00).
Analyst Larry Biegelsen says the product cycle is hitting a lull and sees headwinds from a plethora of competitive challenges in cardiac/vascular... More